Proteologics Ltd (Israel) Performance

PRTL -- Israel Stock  

null 0.70  0.00  0.00%

Proteologics Ltd has performance score of 0 on a scale of 0 to 100. The organization holds Beta of 0.0 which implies the returns on MARKET and Proteologics Ltd are completely uncorrelated. Although it is extremely important to respect Proteologics Ltd current trending patterns, it is better to be realistic regarding the information on equity existing price patterns. The philosophy towards forecasting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Proteologics Ltd technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Proteologics Ltd right now holds a risk of 0.0%. Please check Proteologics Ltd Information Ratio, Treynor Ratio, Value At Risk, as well as the relationship between Jensen Alpha and Maximum Drawdown to decide if Proteologics Ltd will be following its historical price patterns.
Horizon     30 Days    Login   to change

Proteologics Ltd Relative Risk vs. Return Landscape

If you would invest  70.00  in Proteologics Ltd on November 10, 2018 and sell it today you would earn a total of  0.00  from holding Proteologics Ltd or generate 0.0% return on investment over 30 days. Proteologics Ltd is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than Proteologics Ltd and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 

Proteologics Ltd Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
PRTL
Based on monthly moving average Proteologics Ltd is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Proteologics Ltd by adding it to a well-diversified portfolio.

Proteologics Ltd Performance Rating

Proteologics Ltd Risk Adjusted Performance Analysis

0

Risk-Adjusted Performance

Over the last 30 days Proteologics Ltd has generated negative risk-adjusted returns adding no value to investors with long positions.

Proteologics Ltd Alerts

Equity Alerts and Improvement Suggestions

Proteologics Ltd is not yet fully synchronised with the market data
Proteologics Ltd has some characteristics of a very speculative penny stock
Proteologics Ltd has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of . Net Loss for the year was (1.44M) with profit before overhead, payroll, taxes, and interest of 2M.
PROTEOLOGICS has accumulated about 8.67M in cash with (775K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Additionally take a look at Your Equity Center. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com